Investors

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating and Corporate Governance Committee
Willie L. Brown, Jr. 
Willie L. Brown, Jr.
Director


Willie L. Brown, Jr., has more than 50 years of political, business and non-profit experience. He is a practicing attorney, community leader and well-respected public official who served over 31 years in the California State Assembly, spending more than 14 years as its Speaker. Following his work in the California State Assembly, Mr. Brown served as the 41st mayor of San Francisco, holding the position from January 1996 until January 2004. His tenure as mayor is marked by many well known, lar... 

   Chairperson
Scott Morrison Financial Expert
Scott Morrison
Director


Scott Morrison brings over 35 years of financial experience helping life sciences companies excel from start-up, through initial product launch, to global expansion.

Mr. Morrison has served as Ernst & Young’s U.S. Life Sciences Leader since 2002 (retired December 2015). He has worked on hundreds of public and private financings, including more than 40 IPOs and 100 follow-on offerings and is considered a recognized expert in the M&A arena. Mr. Morrison has a long history of contr... 

Chairperson Committee Member  
Deval L. Patrick 
Deval L. Patrick
Director


Deval L. Patrick is an experienced business and government leader with a record of success in solving complex problems, making strategic investments, managing crises and building teams locally, nationally and internationally. He served as the governor of Massachusetts from 2007 to 2015, during which time he oversaw a more than $36 billion balanced budget and over 44,000 employees. As governor, Mr. Patrick is credited with leading Massachusetts through global economic collapse, weather and wat... 

Committee Member Committee Member  
Mark L. Perry Financial Expert
Mark L. Perry
Director


Mark L. Perry brings more than 30 years of experience serving in professional and management positions in the biotechnology industry. He is currently an independent consultant and board member of various companies, following a year as an Entrepreneur-in-Residence at Third Rock Ventures. From 2007 to 2011, Mr. Perry held the position of president and chief executive officer of Aerovance, a biotechnology company spun out of Bayer Corporation. Prior to joining Aerovance, he was the senior busine... 

Committee Member Chairperson  
Philip Pizzo, M.D. 
Philip Pizzo, M.D.
Director


Philip Pizzo, M.D., is a leader in academic medicine, championing programs and policies to improve the future of science, education and healthcare in the United States and beyond. He currently serves as the David and Susan Heckerman Professor of Pediatrics and of Microbiology and Immunology at Stanford School of Medicine and is a founding director of the Stanford Distinguished Careers Institute.  He previously served as Dean of the Stanford School of Medicine from 2001 to 2012, where h... 

   Committee Member
Wendy L. Yarno 
Wendy L. Yarno
Director


Ms. Yarno has served as a member of GBT’s board of directors since December 2017. She has more than 25 years of experience in the biopharmaceutical industry, including at Merck & Co., Inc., where she held positions of increasing seniority, most recently as chief marketing officer. In that position, she led a global organization charged with all aspects of supporting pre-and post-launch commercialization of pharmaceuticals in more than 20 therapeutic areas. She also served as general manager, C... 
  Committee Member